← FDA Drug Approvals (Drugs@FDA)

EVRYSDI

NDA · New Drug Application · Sponsor: GENENTECH INC · Approved 2020-08-07

Drug application

FDA Application #

NDA213535

Application type

New Drug Application

Brand name

EVRYSDI

Generic name

RISDIPLAM

Active ingredients

RISDIPLAM

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2020-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown